Preventive chemotherapy for the control of strongyloidiasis in school-age children: Estimating the ivermectin need.
Donal BisanzioAntonio MontresorMichael FrenchRichard ReithingerPaola RodariZeno BisoffiDora BuonfratePublished in: PLoS neglected tropical diseases (2021)
Our analysis may support endemic countries to evaluate the ivermectin quantity needed for integrating strongyloidiasis in the existing STH programs. These estimates might also show to generic drug manufacturers the size of the potential market for ivermectin and encourage its production.